v3.25.2
Stock-based Compensation (Tables)
6 Months Ended
Jun. 30, 2025
Stock-based Compensation  
Schedule of stock-based compensation expense

Three Months Ended

Six Months Ended

June 30, 

June 30, 

    

2025

    

2024

    

2025

    

2024

    

Research and development

$

1,495

$

418

$

2,480

$

652

General and administrative

 

1,816

 

348

 

3,102

 

738

$

3,311

$

766

$

5,582

$

1,390

Schedule of of stock options activity under the plan

Weighted

Weighted

average

average

remaining

Aggregate

exercise

contractual

Intrinsic Value

    

Options

    

price

    

term (years)

    

(in thousands)

Outstanding as of December 31, 2024

 

2,531,144

$

6.77

 

Granted

 

1,884,923

 

26.60

 

 

Exercised

 

(90,450)

 

4.08

 

Forfeited/Expired

Outstanding as of June 30, 2025

 

4,325,617

15.46

$

8.61

$

37,016

Exercisable as of June 30, 2025

 

1,202,144

4.90

 

7.39

20,279

Vested and expected to vest at June 30, 2025

 

4,325,617

$

15.46

$

8.61

$

37,016

Schedule of assumptions used in estimating the fair value of options

Six Months Ended

June 30, 

    

2025

    

2024

    

Risk-free interest rate

 

3.92% - 4.37%

3.85% - 4.66%

Expected term

 

5.5 - 6.1 years

 

5.5 - 6.1 years

Expected volatility

 

97.2% - 98.3%

93.1% - 98.6%

Expected dividend yield

 

 

Estimated fair value of the Company's common stock per share (a)

$

18.03 - 27.56

 

$

5.85 - 16.14

(a) Subsequent to the Company’s initial public offering on January 24, 2024, the fair value of common stock is based on the closing market price of common stock at the date of grant.